nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibiotic allergy
|
Blumenthal, Kimberly G |
|
2019 |
393 |
10167 |
p. 183-198 |
artikel |
2 |
A two-drug regimen for antiretroviral therapy
|
Kroidl, Arne |
|
2019 |
393 |
10167 |
p. 106-108 |
artikel |
3 |
Canada to widen its newly opened retail cannabis market
|
Webster, Paul |
|
2019 |
393 |
10167 |
p. 116 |
artikel |
4 |
Cervical cancer
|
Cohen, Paul A |
|
2019 |
393 |
10167 |
p. 169-182 |
artikel |
5 |
Cervical cancer: unequal progress
|
The Lancet, |
|
2019 |
393 |
10167 |
p. 104 |
artikel |
6 |
Confronting the most challenging risk factor: non-adherence
|
Kones, Richard |
|
2019 |
393 |
10167 |
p. 105-106 |
artikel |
7 |
Department of Error
|
|
|
2019 |
393 |
10167 |
p. 132 |
artikel |
8 |
Department of Error
|
|
|
2019 |
393 |
10167 |
p. 132 |
artikel |
9 |
Department of Error
|
|
|
2019 |
393 |
10167 |
p. 132 |
artikel |
10 |
Department of Error
|
|
|
2019 |
393 |
10167 |
p. 132 |
artikel |
11 |
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
|
Cahn, Pedro |
|
2019 |
393 |
10167 |
p. 143-155 |
artikel |
12 |
Framing an agenda for children thriving in the SDG era: a WHO–UNICEF–Lancet Commission on Child Health and Wellbeing
|
Coll-Seck, Awa |
|
2019 |
393 |
10167 |
p. 109-112 |
artikel |
13 |
Head of Italian research institute resigns over “anti-scientific position” of government
|
Burki, Talha |
|
2019 |
393 |
10167 |
p. 115 |
artikel |
14 |
Health-emergency disaster risk management and research ethics
|
Chan, Emily Y Y |
|
2019 |
393 |
10167 |
p. 112-113 |
artikel |
15 |
Hyperphosphataemic tumoral calcinosis
|
Tiwari, Vivek |
|
2019 |
393 |
10167 |
p. 168 |
artikel |
16 |
2019 in the USA: shutdowns and showdowns
|
The Lancet, |
|
2019 |
393 |
10167 |
p. 103 |
artikel |
17 |
Laennec's cirrhosis
|
Braillon, Alain |
|
2019 |
393 |
10167 |
p. 131-132 |
artikel |
18 |
Logistical challenges in the DR Congo Ebola virus response
|
Shuchman, Miriam |
|
2019 |
393 |
10167 |
p. 117-118 |
artikel |
19 |
Multimorbidity and patient-centred care in the 3D trial
|
Marengoni, Alessandra |
|
2019 |
393 |
10167 |
p. 127-128 |
artikel |
20 |
Multimorbidity and patient-centred care in the 3D trial
|
Sturgiss, Elizabeth Ann |
|
2019 |
393 |
10167 |
p. 127 |
artikel |
21 |
Multimorbidity and patient-centred care in the 3D trial
|
Xu, Zhijie |
|
2019 |
393 |
10167 |
p. 128-129 |
artikel |
22 |
Multimorbidity and patient-centred care in the 3D trial
|
Lewis-Barned, Nick |
|
2019 |
393 |
10167 |
p. 127 |
artikel |
23 |
Multimorbidity and patient-centred care in the 3D trial – Authors' reply
|
Salisbury, Chris |
|
2019 |
393 |
10167 |
p. 129 |
artikel |
24 |
Offline: Rosa Luxemburg and the struggle for health
|
Horton, Richard |
|
2019 |
393 |
10167 |
p. 114 |
artikel |
25 |
PD-1 antibodies in head-and-neck cancer
|
Wollenberg, Barbara |
|
2019 |
393 |
10167 |
p. 108-109 |
artikel |
26 |
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|
Cohen, Ezra E W |
|
2019 |
393 |
10167 |
p. 156-167 |
artikel |
27 |
Picturing health: living with bipolar disorder
|
Zellweger, Matthieu |
|
2019 |
393 |
10167 |
p. 119-126 |
artikel |
28 |
Snakebite envenoming
|
Bawaskar, Himmatrao Saluba |
|
2019 |
393 |
10167 |
p. 131 |
artikel |
29 |
Snakebite envenoming
|
Hunter, Christian John |
|
2019 |
393 |
10167 |
p. 129-131 |
artikel |
30 |
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
|
Näslund, Ulf |
|
2019 |
393 |
10167 |
p. 133-142 |
artikel |
31 |
Was DR Congo's Ebola virus outbreak used as a political tool?
|
The Lancet, |
|
2019 |
393 |
10167 |
p. 104 |
artikel |